GSA Capital Partners LLP cut its stake in Waters Co. (NYSE:WAT) by 68.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,694 shares of the medical instruments supplier’s stock after selling 3,734 shares during the period. GSA Capital Partners LLP’s holdings in Waters were worth $304,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of Waters by 2.8% during the 2nd quarter. Vanguard Group Inc. now owns 7,704,022 shares of the medical instruments supplier’s stock worth $1,416,308,000 after purchasing an additional 206,262 shares in the last quarter. BlackRock Inc. increased its stake in shares of Waters by 3.1% during the 2nd quarter. BlackRock Inc. now owns 5,515,322 shares of the medical instruments supplier’s stock worth $1,013,936,000 after purchasing an additional 165,611 shares in the last quarter. Fundsmith LLP increased its stake in shares of Waters by 11.7% during the 2nd quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after purchasing an additional 401,420 shares in the last quarter. Harding Loevner LP increased its stake in shares of Waters by 207.1% during the 3rd quarter. Harding Loevner LP now owns 2,768,174 shares of the medical instruments supplier’s stock worth $158,275,000 after purchasing an additional 1,866,848 shares in the last quarter. Finally, Janus Henderson Group PLC increased its stake in shares of Waters by 1.6% during the 3rd quarter. Janus Henderson Group PLC now owns 1,959,850 shares of the medical instruments supplier’s stock worth $351,832,000 after purchasing an additional 30,057 shares in the last quarter. 92.12% of the stock is owned by institutional investors.
A number of research analysts have recently weighed in on WAT shares. Cowen reissued a “hold” rating and set a $190.00 price objective on shares of Waters in a research note on Friday, November 3rd. Morgan Stanley raised shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price objective for the company in a research note on Monday, December 4th. Zacks Investment Research cut shares of Waters from a “buy” rating to a “hold” rating in a research note on Thursday, October 26th. Deutsche Bank raised their price objective on shares of Waters from $199.00 to $200.00 and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Finally, Bank of America raised their target price on shares of Waters from $192.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, November 10th. Eleven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $197.33.
Shares of Waters Co. (WAT) opened at $208.96 on Wednesday. Waters Co. has a 1 year low of $136.14 and a 1 year high of $210.08. The stock has a market cap of $16,620.00, a P/E ratio of 30.82, a P/E/G ratio of 2.71 and a beta of 0.82. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16.
Waters (NYSE:WAT) last announced its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.03. Waters had a net margin of 24.34% and a return on equity of 23.61%. The firm had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same quarter last year, the business earned $1.57 earnings per share. Waters’s revenue was up 7.4% compared to the same quarter last year. analysts forecast that Waters Co. will post 7.42 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This piece was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2018/01/10/waters-co-wat-shares-sold-by-gsa-capital-partners-llp.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.